Download AuE!@ool

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
DEPARTMENT
Public Health Service
OF HEALTH & HUMAN SERVICES
Food and Drug Administration
Washington, DC 20204
5,
!*
,,
2
..’
_
AuE!@ool
-..
Mr. Mark F. Sever
President
EuropeanLifestyle Products,LLC
P. 0. Box 1345
Gibsonia, Pennsylvania15044
Dear Mr. Sever:
This is in responseto your letter of August 8, 2001 to the Food and Drug
Administration (FDA) pursuantto 21 U.S.C. 343(r)(6) (section403(r)(6) of the Federal
Food, Drug, and CosmeticAct (the Act)). Your submissionstatesthat European
Lifestyle Products,LLC is making the following claim, among others, for the product
Polyerga Plusm:
L(.. .producesthe white blood cells that defend the body against infection.”
21 U.S.C. 343(r)(6) makesclear that a statementincluded in labeling under the
authority of that section may not claim to diagnose,mitigate, treat, cure, or prevent a
specific diseaseor class of diseases. The statementthat you are making for this product
suggeststhat it is intended to treat, prevent, or mitigate a disease,namely infectious
disease. This claim does not meet the requirements’of 21 U.S .C. 343(r)(6). This claim
suggeststhat this product is intended for use as a drug within the meaning of 21 U.S.C.
321(g)(l)(B), and that it is subjectto regulation under the drug provisions of the Act. If
you intend to make claims of this nature, you should contactFDA’s Center for Drug
Evaluation and Research(CDER), Office of Compliance,HFD-3 lo,7520 StandishPlace,
Rockville, Maryland 20855.
“.-
Page2 - Mr. Mark F. Sever
Pleasecontact us if you require further assistance.
Sincerely,
‘f>*
n-ector
Division of Complianceand Enforcement
Offrce of Nutritional Products,Labeling,
and Dietary Supplements
Center for Food Safety
and Applied Nutrition
Copies:
FDA, Center for Drug Evaluation and Research,Office of Compliance,HFD-300
FDA, Office of the AssociateCommissionerfor RegulatoryAffairs, Office of
Enforcement,HFC-200
~
FDA, PhiladelphiaDistrict Compliance,HFR-MA140
.
Overnight Mail
August 8,200l
Office of SpecialNutritionals (HFS-450)
Center for Food Safetyand Applied Nutrition
Food and Drug Administration
200 C Street, S.W.
Washington D.C. 20204
Ref. Polverga PlusTMDietarv Supplement
Dear Sir and/or Madam:
This is a notification pursuantto Section403(r)(6
CosmeticAct that EuropeanLifestyle Products,LLC, Gibsonia,Pennsylvania15044,
has, within the past 30 days,begunmarketing its immune systemboosterproduct
“‘PolyergaPlusRv”’using the following statements:
l
0
The spleen,an organ in the lymphatic,system,performs many different blood cell
related activities. The spleenproducesthe white blood cells that defendthe body
againstinfection. It also stores,destroysor recyclesred cells and plateletsas needed.
The human spleenreleasesseveralsubstancesthat activatethe immune system.The
most active compoundsare small peptides.
PolyergaPlusTMcontainsoligo- and polypeptidesfrom porcine spleenthat provide
nutritional ingredientsto support health.
0 PolyergaPlusTMhas, for more than 50 years,improved energy levels and the general
senseof well-being.
0 PolyergaPlusm appearsto contain immune systemactivatorsthat supportthe natural
immune system.
Thesestatementsare made for a dietary supplementcontaining a proprietary blend of
porcine spleenpeptides.Inactive ingredients include sucrose,takqnirocrystalline
cellulose,calcium carbonate,clay, polyvinyl pyrrolidone, powdered cellulose,acacia,
shellac,corn syrup, titanium dioxide, magnesiumstearate,cornstarch,silicon dioxide,
ferric oxide, polyethylene glycol (MW 6000), montan glycol wax, castoroil,
polyoxylated castoroil, lactose,gelatine, rapeseedoiLglycerin, partially hydrogenated
soybeanoil, beeswax,hydrogenatedsoybeanoil, lecithin, water, dibutylphalate and
hyroxpropyl methylcellulosephthalate.
P.O. Box 1345 Gibsonia, PA 15044 724-934-3068
FAX 724-934-9181
\
Polyergd
--PfiJS
Smlng
We ,,I
ArnO”nt
Perlablet
One
Polyerga”
Polyerga”
-.-.J?lUS
Plus
Tablet or Capsule
Amount
D
Polyerga”
Plus
A Dietary Supplement
A Dietary Supplement
Per Capsule
Ollgopeptid~from
porckle spleen
extract Knmcg*
DIRECTK)NS FOR USE: For IndMduals
‘I8 years of age Or Older, take as
recommended
below.
lbblets:Takeo”e
Wtabktttwee
(31
Umes dally before meab.
CaprulescTakeaddltlonalQone
(II
capsule werv other day before a meal.
Wallv Value not establistwxl.
Stme I,, a Cool l”Ot abOW 7SW dry place.
KEEP OUT OF REACH OF C”lLMlEN.
WW.EUROPEANLIFFW”LEPRODUCTS.COM
8
13492 00001
o
Polyerga”
Plus
COOGO
AdH Nl :‘ON Wd
/
Batch
EXP
\
-
1
I
!.
I
.
PQLYERGA PLUSTM
m The spleen, an organ in the lymphatic system, performs many
different blood cell related activities. The spleen produces the-white
blood cells that defend the body against infection. It also stores,
destroys or recycles red cells and platelets as needed. TheNhuman
spleen releases several substances that activate the immune system.
The most active compounds are small peptides.
0
Polyerga PlusTMcontains oligo- and polypeptides from porcine
spleen that provide nutritional ingredients to support health.
0 Polyerga PlusTMhas, for more than 50 years, improved energy levels
and the general sense of well-being.
0 Polyerga PlusTMappears to contain immune system activators that
support the natural immune system.
These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat, cure or
prevent any disease.